Vident Advisory, LLC Adaptive Biotechnologies Corp Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
A detailed history of Vident Advisory, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Vident Advisory, LLC holds 48,016 shares of ADPT stock, worth $276,092. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,016
Previous 35,487
35.31%
Holding current value
$276,092
Previous $114 Million
52.59%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ADPT
# of Institutions
185Shares Held
153MCall Options Held
8.4KPut Options Held
56K-
Viking Global Investors LP30MShares$172 Million0.43% of portfolio
-
Rubric Capital Management LP New York, NY14MShares$80.5 Million1.5% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$67.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$66.7 Million0.56% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$66.5 Million0.32% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $822M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...